readalot
Member
Some thoughts/suggestions for discussion after looking around here.
Realistic, overkill, get what you pay for, don't care?
Would like to hear members' thoughts, counterpoints, etc. especially on cost vs quality. The path to quality is known. Will people pay or too much for UGL customers?
=======
Every Source should provide with each shipment ...
1. 3rd party C of A on finished product batch specific to that shipment
- endotoxin screen
- metals with ICP
- purity(ies) / concentration(s) using hplc plus ms (or gcms)
2. C of A for bulk api for each batch (hplc plus ms or gcms) upon request.
Of course Sources would do themselves a big favor if they screened for impurities as well as purity on the APIs (aka raws) upfront so no surprises on the finished batches. First things first.
There should never be any surprises with a batch. Completely addressable.
And please clean up the product listings...
1. mg is not a unit for API concentration. Use mg/ml.
If I see 200 mg listed and later on a mention that it is a 10 ml vial I am going to assume your stuff is drastically underdosed. That should be clear to you to.
Best practice is listing the API concentration plus the total API per total vial volume.
Example: 300 mg/ml (3000 mg per 10 ml)
2. Denote volumes (ml) for finished vials. People don't want to guess.
3. List the oil used for injectables and also the excipients/preservatives used plus their concentrations.
What is this deal with not disclosing what is in the vial? You don't know, or is it a trade secret lol? Come on.
4. Spend at least as much time assuring your customer you know basic chemistry as you spend on the beautiful packaging design and gimmicks/marketing.
Be the change.
======
Is this a template Meso should endorse for Sources? Even daylighting the concepts with a suggested template would go a long way to educate consumer and further harm reduction initiative IMO.
Realistic, overkill, get what you pay for, don't care?
Would like to hear members' thoughts, counterpoints, etc. especially on cost vs quality. The path to quality is known. Will people pay or too much for UGL customers?
=======
Every Source should provide with each shipment ...
1. 3rd party C of A on finished product batch specific to that shipment
- endotoxin screen
- metals with ICP
- purity(ies) / concentration(s) using hplc plus ms (or gcms)
2. C of A for bulk api for each batch (hplc plus ms or gcms) upon request.
Of course Sources would do themselves a big favor if they screened for impurities as well as purity on the APIs (aka raws) upfront so no surprises on the finished batches. First things first.
There should never be any surprises with a batch. Completely addressable.
And please clean up the product listings...
1. mg is not a unit for API concentration. Use mg/ml.
If I see 200 mg listed and later on a mention that it is a 10 ml vial I am going to assume your stuff is drastically underdosed. That should be clear to you to.
Best practice is listing the API concentration plus the total API per total vial volume.
Example: 300 mg/ml (3000 mg per 10 ml)
2. Denote volumes (ml) for finished vials. People don't want to guess.
3. List the oil used for injectables and also the excipients/preservatives used plus their concentrations.
What is this deal with not disclosing what is in the vial? You don't know, or is it a trade secret lol? Come on.
4. Spend at least as much time assuring your customer you know basic chemistry as you spend on the beautiful packaging design and gimmicks/marketing.
Be the change.
======
Is this a template Meso should endorse for Sources? Even daylighting the concepts with a suggested template would go a long way to educate consumer and further harm reduction initiative IMO.
Last edited:
